abstract |
The present invention relates to a composition composed of a therapeutically effective amount of beta 4 thymosin, LKKTET or LKKTNT amino acid sequences, and / or any conservative variant thereof, or an agent that stimulates the production of any of these materials, or a conservative variant of this one; to promote the recovery of peripheral neuropathy in a subject. |